Table 3.
Baseline medications of patients in the clopidogrel and ticagrelor groups, n (%).
Clopidogrel | Ticagrelor | P value | |
---|---|---|---|
(n = 223) | (n = 214) | ||
Statins | 219 (98.2%) | 210 (98.1%) | 1 |
Beta-blockers | 154 (69.1%) | 132 (61.7%) | 0.109 |
Diuretics | 29 (13%) | 22 (10.3%) | 0.456 |
Calcium channel blockers | 47 (21.1%) | 41 (19.2%) | 0.635 |
Angiotensin-converting enzyme inhibitors | 32 (14.3%) | 13 (6.1%) | 0.005 |
Angiotensin II receptor blockers | 86 (38.6%) | 93 (43.5%) | 0.331 |
Nitrates | 75 (33.6%) | 106 (49.5%) | 0.001 |
Proton pump inhibitors | 78 (35%) | 85 (39.7%) | 0.323 |